Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Showing 20 of 0 results

Not applicableUnknownNCT01426204
What this trial is testing

Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1)

Who this might be right for
Hepatitis C
Closter Pharma 40
Post-approval studies (Phase 4)Study completedNCT00629967
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

Who this might be right for
Chronic Hepatitis CGenotype
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Post-approval studies (Phase 4)Study completedNCT00493077
What this trial is testing

Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy

Who this might be right for
Multiple Sclerosis
Biogen 3
Very early researchEnded earlyNCT01957709
What this trial is testing

Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Myxoid LiposarcomaRound Cell LiposarcomaSynovial Sarcoma
Fred Hutchinson Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT00467077
What this trial is testing

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
California Cancer Consortium 21
Large-scale testing (Phase 3)Study completedNCT00292266
What this trial is testing

Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
EMD Serono 677
Not applicableUnknownNCT01599130
What this trial is testing

Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss

Who this might be right for
Hepatitis B
Sun Yat-sen University 60
Large-scale testing (Phase 3)Study completedNCT00416429
What this trial is testing

Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Centre Leon Berard 456
Not applicableUnknownNCT06450145
What this trial is testing

Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL

Who this might be right for
Tumour
Zhejiang Provincial People's Hospital 15
Large-scale testing (Phase 3)Study completedNCT02006745
What this trial is testing

Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)

Who this might be right for
HIV
St Stephens Aids Trust 20
Not applicableStudy completedNCT00336557
What this trial is testing

Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,230
Testing effectiveness (Phase 2)Study completedNCT00987337
What this trial is testing

Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

Who this might be right for
HepatitisHepatitis C
Pfizer 288
Not applicableNot Yet RecruitingNCT06371235
What this trial is testing

Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier

Who this might be right for
Woman Suffering From a Pathology Frequently Associated With the Presence of These Anti-autoantibodies Type-I Interferons
CerbaXpert 250
Not applicableStudy completedNCT01142492
What this trial is testing

A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 403
Post-approval studies (Phase 4)Study completedNCT02064049
What this trial is testing

Surveillance and Treatment of Prisoners With Hepatitis C

Who this might be right for
Hepatitis C
Kirby Institute 3,692
Not applicableStudy completedNCT05054114
What this trial is testing

Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19

Who this might be right for
COVID-19 Respiratory InfectionAcute Respiratory Disease
SPP Pharmaclon Ltd. 630
Testing effectiveness (Phase 2)Ended earlyNCT03119701
What this trial is testing

Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After Open Surgery for a RAAA

Who this might be right for
Preventive MedicineMulti Organ Failure
Faron Pharmaceuticals Ltd 40
Not applicableStudy completedNCT04655222
What this trial is testing

Study to Investigate Pregnancy Outcomes in Female Participants Exposed to Subcutaneous (SC) Peginterferon Beta-1a and Intramuscular (IM) Interferon Beta-1a Reported in a German Participant Support Program

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Biogen 470
Testing effectiveness (Phase 2)Study completedNCT00276523
What this trial is testing

PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT01440595
What this trial is testing

Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 5
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation